本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

和黄医药

14.81
-0.2700-1.79%
成交量:1.27万
成交额:18.80万
市值:25.83亿
市盈率:5.59
高:14.95
开:14.89
低:14.74
收:15.08
52周最高:19.50
52周最低:11.51
股本:1.74亿
流通股本:1.04亿
量比:0.65
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):2.65
每股收益(LYR):0.2205
净资产收益率:46.90%
总资产收益率:-0.81%
市净率:2.10
市盈率(LYR):67.15

数据加载中...

2020/01/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses